-
LMO2–LDB1 Signaling in Acute Myeloid Leukemia
2026-09-30
The reference study identifies an LMO2/LDB1 protein complex as a functional driver of acute myeloid leukemia (AML) cell growth, survival, and clonogenicity. By combining protein-interaction analysis, genetic perturbation, transcriptomics, and chromatin profiling, it moves LMO2 research beyond prognostic association toward a mechanistic model involving LDB1-dependent regulation of apoptosis-related genes.
-
H 89 2HCl: Mapping cAMP–PKA Pain Signaling
2026-09-29
H 89 2HCl enables mechanistic analysis of cAMP/PKA signaling in trigeminal pain models. This article connects its biochemical selectivity and cellular limitations with the CGRP/SP–Piezo2 findings of recent nerve-root compression research to improve assay design and interpretation.
-
Forskolin: Adenylate Cyclase Activator Guide
2026-09-29
Forskolin is a direct adenylate cyclase activator that raises intracellular cAMP and supports mechanistic studies of inflammation, neuronal signaling, stem-cell biology, and cardiovascular disease research. The B1421 product is water-insoluble and is typically prepared in DMSO for controlled in vitro experiments.
-
CGK733: Reliable Cell Assay Planning
2026-09-28
CGK733 (SKU A8624) can be incorporated into a controlled cell-based testing workflow when compound identity, vehicle exposure, assay linearity, and biological interpretation are managed explicitly. This evidence-focused guide helps researchers evaluate CGK733 without confusing a test compound with a viability readout.
-
Hexetidine and Copper: Designing Synergy Assays
2026-09-28
Hexetidine (NSC-17764) is more than a standalone oral antimicrobial: its interaction with copper provides a useful model for testing combination effects in oral microbiology. This article unpacks the foundational streptococcal study and turns its methods into practical assay-design decisions.
-
H 89 2HCl for PKA Signaling Experiments
2026-09-27
Use H 89 2HCl to test whether PKA activity contributes to rapid neuronal signaling changes, including glucocorticoid-linked calcium responses. This guide connects the reference study to practical inhibitor workflows, controls, and selectivity-aware interpretation.
-
Genistein Workflows for Signaling and Autophagy Research
2026-09-26
Use Genistein to probe growth-factor signaling and cell proliferation inhibition, while keeping its effects distinct from mechanical-stress autophagy. This guide pairs practical dose-finding and assay controls with a cautious framework for connecting kinase signaling to cytoskeleton-dependent responses.
-
Etoposide (VP-16): Assays, Delivery & Optimization
2026-09-25
Use Etoposide (VP-16) to connect topoisomerase II–linked DNA damage with cell-death readouts, while tailoring dose and timing to the model rather than treating IC50 values as universal. A preclinical nanoparticle–hydrogel study also illustrates how etoposide research can extend from standard cell assays to localized delivery questions after brain-tumor resection.
-
How the Cytoskeleton Shapes Stress-Induced Autophagy
2026-09-25
Liu et al. examine how cytoskeletal structures contribute to autophagy triggered by compression in human cell lines. Their results identify microfilaments as a central requirement for changes in autophagosome number, with microtubules playing an auxiliary role, sharpening the mechanistic picture of cellular responses to force.
-
hiPSC Intestinal Organoids for Pharmacokinetic Studies
2026-09-24
Saito and colleagues describe a human iPSC-derived intestinal organoid platform designed to simplify production while preserving long-term expansion, cryopreservation, and differentiation capacity. When converted to monolayers, the organoids produced intestinal epithelial cells with drug-metabolizing enzyme and transporter activities, supporting their use in in vitro pharmacokinetic research.
-
Caffeic Acid Phenethyl Ester in Neuroinflammation
2026-09-24
Caffeic Acid Phenethyl Ester (CAPE) offers a way to test NF-κB involvement in Fyn-driven neuroinflammation—but not to assume that pathway explains every phenotype. This article connects recent zebrafish findings to a rigorous, cell-aware assay strategy and clarifies where CAPE evidence does and does not transfer.
-
Trigeminal Compression, Neuroinflammation, and Piezo2
2026-09-23
Liao et al. connect chronic trigeminal root compression to peripheral neuroinflammation and mechanical allodynia through a calcium-dependent CGRP/SP–Piezo2 signaling loop. Their rat and in vitro findings implicate both PKC-related regulation and cAMP-sensitive processes, while leaving the precise contribution of PKA and the pathway’s relevance to human trigeminal neuralgia open for testing.
-
Defactinib and the Next Era of FAK Translation
2026-09-23
Defactinib offers translational researchers a way to connect FAK Tyr397 target engagement with chemoresistance, paclitaxel combinations, and phosphoproteomic strategy. This article explains how to build evidence across ovarian cancer models while using a recent Zika phosphoproteome study as a methodological, not disease-specific, guide.
-
Neuroligin 1, D2-MSNs, and Repetitive Behavior
2026-09-22
This study identifies Neuroligin 1 loss in striatal dopamine D2 receptor-expressing medium spiny neurons as a circuit-level driver of excessive self-grooming and digging in mice. By combining cell-type-specific manipulation, behavioral analysis, activity measurements, and single-nucleus RNA sequencing, the work links D2-MSN hyperactivation to repetitive behavior and implicates excessive protein kinase C activity as a molecular contributor.
-
Mecamylamine Hydrochloride: nAChR Research Guide
2026-09-22
Mecamylamine hydrochloride is a brain-penetrant, non-competitive nicotinic acetylcholine receptor antagonist for mechanistic neuropsychiatric research. Product data report an IC50 of 7.8 μM and antidepressant-like effects in C57BL/6J mice at 0.5–1 mg/kg by intraperitoneal injection, while gut-brain epilepsy evidence supports a carefully bounded use as a receptor-perturbation tool rather than a validated antiseizure treatment.